The suggested biomarkers to be included in the proposed definition of AECOPD are: CRP ≥3 mg/L and ≥70% circulating neutrophils in the diagnosis of AECOPD; PCT as an indicator of bacterial infection and therefore for the use antibiotics; and pro-BNP as a marker for cardiac dysfunction (differential diagnosis). The gene discussed is CRP; the disease is bacterial infectious disease.